LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 1 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,838,545 | -49.8% | 1,250,711 | +8.6% | 0.00% | 0.0% |
| Q2 2023 | $3,663,389 | +36.2% | 1,152,009 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $2,689,159 | -31.6% | 1,139,474 | +0.6% | 0.00% | 0.0% |
| Q4 2022 | $3,931,010 | -51.8% | 1,132,856 | +1.9% | 0.00% | -66.7% |
| Q3 2022 | $8,152,000 | +155.5% | 1,112,110 | +127.3% | 0.00% | +200.0% |
| Q2 2022 | $3,190,000 | +39.4% | 489,207 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $2,289,000 | +72.6% | 453,144 | +164.7% | 0.00% | – |
| Q4 2021 | $1,326,000 | -46.1% | 171,206 | +3.0% | 0.00% | -100.0% |
| Q3 2021 | $2,461,000 | – | 166,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $101,820,000 | 43.09% |
| Apoletto Ltd | 15,093,969 | $76,225,000 | 20.06% |
| Foresite Capital Management IV, LLC | 13,282,181 | $67,075,000 | 18.76% |
| HSG Holding Ltd | 3,045,997 | $15,382,000 | 1.92% |
| MIC Capital Management UK LLP | 1,320,000 | $6,666,000 | 1.30% |
| Alphabet Inc. | 5,865,125 | $29,619,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $8,322,000 | 0.47% |
| Adero Partners, LLC | 253,512 | $1,280,000 | 0.19% |
| Artal Group S.A. | 700,000 | $3,535,000 | 0.15% |
| Eagle Health Investments LP | 100,000 | $505,000 | 0.12% |